Logo Image
News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Dr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA

Advertisement

Articles by Dr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA

Real World insights with EYLEA 8mg

ByDr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA
July 14th 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, PhD

    2

    Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease

    3

    StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101

    4

    CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us